Colette DeJong (@colettedejong) 's Twitter Profile
Colette DeJong

@colettedejong

@UCSFCardiology fellow, @UCSFIMChiefs and @brownuniversity alum. Interested in improving access to CV therapies. Views my own šŸ³ļøā€šŸŒˆ

ID: 52140048

calendar_today29-06-2009 18:24:30

55 Tweet

150 Followers

318 Following

Stacey Abrams (@staceyabrams) 's Twitter Profile Photo

Georgia, thank you. Together, we have changed the course of our state for the better. But our work is not done. Join me in supporting Reverend Raphael Warnock and Jon Ossoff so we can keep up the fight and win the U.S. Senateāž”ļøGASenate.com #LetsGetItDoneAgain #gapol

Emily Oster (@profemilyoster) 's Twitter Profile Photo

Breaking down some numbers on post-vaccine risks of transmission, seeing family. And a meditation on how we think about risk. emilyoster.substack.com/p/vaccines-and…

Monica Gandhi MD, MPH (@monicagandhi9) 's Twitter Profile Photo

CDC looking carefully whether 3rd shots needed for immunocompromised -likely will. Vax still doing a very good job at preventing severe infection/hospitalizations/deaths in those vax'd which is what vaccines do. Need to shift our conversation to viral load washingtonpost.com/outlook/2021/0…

Colette DeJong (@colettedejong) 's Twitter Profile Photo

The amazing Dhruv Kazi at the #ACC23 heart failure year in review- the #InflationReductionAct will cap out of pocket costs at $2K/year for #MedicarePartD patients, reducing OOP costs by 13-87% for 4 CV conditions #ACCWIC BIDMC Smith Center

The amazing <a href="/kardiologykazi/">Dhruv Kazi</a> at the #ACC23  heart failure year in review- the #InflationReductionAct will cap out of pocket costs at $2K/year for #MedicarePartD patients, reducing OOP costs by 13-87% for 4 CV conditions #ACCWIC  <a href="/SmithBIDMC/">BIDMC Smith Center</a>
Jackie DesJardin, MD (@jtdesjardin) 's Twitter Profile Photo

I knew my co-fellow Leila Haghighat, MD MPhil was an amazing cardiologist and awesome friend, but I didn’t know she was also such a talented writer/journalist! Awesome article on unionization of housestaff, with a focus on CIR/SEIU and UCSF School of Medicine. wired.com/story/health-d… via @wired

UCSF HIVIDGM (@ucsf_hividgm) 's Twitter Profile Photo

Which people living with HIV should be on statins after REPRIEVE? And which statin?? Watch some world experts break it down during last week's HIV Grand Rounds: youtube.com/watch?v=L4pnRH… šŸ‘ Dr. Peter Hunt, Dr. Priscilla Hsue, Dr. Colette Dejong

Which people living with HIV should be on statins after REPRIEVE? And which statin?? 

Watch some world experts break it down during last week's HIV Grand Rounds: youtube.com/watch?v=L4pnRH…

šŸ‘ Dr. Peter Hunt, Dr. Priscilla Hsue, Dr. Colette Dejong
Dhruv Kazi (@kardiologykazi) 's Twitter Profile Photo

7 of the first 10 drugs selected for price negotiation by Medicare are used to treat cardiovascular disease or risk factors. Huge win for US adults with CVD – but there’s a catch (a good one, for a change). bit.ly/3t2Qnrx @jama_current with Rishi Wadhera, MD MPP and Ben Rome 1/

7 of the first 10 drugs selected for price negotiation by Medicare are used to treat cardiovascular disease or risk factors.

Huge win for US adults with CVD – but there’s a catch (a good one, for a change).

bit.ly/3t2Qnrx

@jama_current with <a href="/rkwadhera/">Rishi Wadhera, MD MPP</a> and <a href="/bnrome/">Ben Rome</a>
1/
UCSF Cardiology (@ucsfcardiology) 's Twitter Profile Photo

Congratulations šŸŽ‰ to Dr. Allison Kratka who wasĀ selected asĀ theĀ California ACCĀ Fellow of the YearĀ for 2023. #WomenInCardiology Allison Kratka, MD California ACC

Congratulations šŸŽ‰ to Dr. Allison Kratka who wasĀ selected asĀ theĀ California ACCĀ Fellow of the YearĀ for 2023. #WomenInCardiology <a href="/akkratka/">Allison Kratka, MD</a> <a href="/CaliforniaACC/">California ACC</a>
American College of Cardiology (@accintouch) 's Twitter Profile Photo

Congratulations to the Merck Research Fellowship Award winners! The ACC is proud to partner with Merck & the Association of Black Cardiologists on this award, providing a year of salary support for one year of research in adult cardiology. #ACC24 Colette DeJong Dennis Narcisse

Congratulations to the Merck Research Fellowship Award winners!

The ACC is proud to partner with Merck &amp; the <a href="/ABCardio1/">Association of Black Cardiologists</a> on this award, providing a year of salary support for one year of research in adult cardiology. #ACC24

<a href="/colettedejong/">Colette DeJong</a> <a href="/dnarcisseMD/">Dennis Narcisse</a>
Circ: CQO (@circoutcomes) 's Twitter Profile Photo

Key stakeholders perceive a HFrEF polypill to be a highly acceptable, feasible, and appropriate strategy to improve care of HFrEF patients WashU Medicine Cardiovascular Division @WUDeptMedicine Matt Durstenfeld, MD MAS Colette DeJong #AHAJournals ahajrnls.org/4hZpKbZ

Key stakeholders perceive a HFrEF polypill to be a highly acceptable, feasible, and appropriate strategy to improve care of HFrEF patients <a href="/WashUCardiology/">WashU Medicine Cardiovascular Division</a> @WUDeptMedicine <a href="/durstenfeld/">Matt Durstenfeld, MD MAS</a> <a href="/colettedejong/">Colette DeJong</a> #AHAJournals
ahajrnls.org/4hZpKbZ
Leila Haghighat, MD MPhil (@leilahaghighat) 's Twitter Profile Photo

Curious about new heart failure drugs in the pipeline? šŸ’Š Colette DeJong @jteerlinkmd and I discuss them in our review paper, along with currently approved drugs. Out in Nature Cardiovascular Research this month: nature.com/articles/s4416…

Curious about new heart failure drugs  in the pipeline? šŸ’Š <a href="/colettedejong/">Colette DeJong</a> @jteerlinkmd  and I discuss them in our review paper, along with currently approved drugs.

Out in <a href="/NatureCVR/">Nature Cardiovascular Research</a>  this month: nature.com/articles/s4416…
Journal of Cardiac Failure (@jcardfail) 's Twitter Profile Photo

To counter pill-burden, a major barrier to HF GDMT adherence, polypills are being investigated. In this #ACCSimPub the authors developed polypill prototypes & manufacturing pathways w/pharmacy partners. Clinical trials are underway to study this strategy.šŸ”—bit.ly/4hQDbty

To counter pill-burden, a major barrier to HF GDMT adherence, polypills are being investigated. In this #ACCSimPub the authors developed polypill prototypes &amp; manufacturing pathways w/pharmacy partners. Clinical trials are underway to study this strategy.šŸ”—bit.ly/4hQDbty
Kosuke Inoue (@ki_endoepi) 's Twitter Profile Photo

In our new paper #JACCHF, led by Colette DeJong, ARNI and SGLT2i marketing to cardiologists was associated with their greater use. The association was specific to the drug marketed, and did not extend to other GDMT pillars. JACC Journals Dhruv Kazi jacc.org/doi/full/10.10…

In our new paper #JACCHF, led by <a href="/colettedejong/">Colette DeJong</a>, ARNI and SGLT2i marketing to cardiologists was associated with their greater use. The association was specific to the drug marketed, and did not extend to other GDMT pillars. <a href="/JACCJournals/">JACC Journals</a> <a href="/kardiologykazi/">Dhruv Kazi</a> 
jacc.org/doi/full/10.10…